These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12408137)
21. Influenza vaccine for healthy working adults. Muennig P JAMA; 2001 Jan; 285(3):291; author reply 292. PubMed ID: 11176834 [No Abstract] [Full Text] [Related]
22. The economic implications of influenza vaccination for adults with asthma. Trogdon JG; Nurmagambetov TA; Thompson HF Am J Prev Med; 2010 Nov; 39(5):403-10. PubMed ID: 20965377 [TBL] [Abstract][Full Text] [Related]
23. Influenza vaccine for healthy working adults. Byrnes GB; Kelly H JAMA; 2001 Jan; 285(3):290-1; author reply 292. PubMed ID: 11176833 [No Abstract] [Full Text] [Related]
24. Opening and continuing the discussion on influenza vaccination timing. Ryan KJ; Rousculp MD Am J Manag Care; 2010 Aug; 16(8):628-9; author reply 629-30. PubMed ID: 20737745 [No Abstract] [Full Text] [Related]
25. Influenza vaccine for healthy adults? Patriarca PA; Strikas RA N Engl J Med; 1995 Oct; 333(14):933-4. PubMed ID: 7666882 [No Abstract] [Full Text] [Related]
26. [Pharmaco-economics of anti-influenza vaccinations]. Jahnz-Rózyk K Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303 [TBL] [Abstract][Full Text] [Related]
27. Establishment of vaccination clinics; user fees for investigational new drug (IND) influenza vaccine services and vaccines. Interim final rule and request for comments. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS) Fed Regist; 2005 Jan; 70(15):3490-3. PubMed ID: 15669145 [TBL] [Abstract][Full Text] [Related]
28. Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza. Tschantz K; Foley LA Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2000 Oct; (IB45):1-9. PubMed ID: 11885591 [No Abstract] [Full Text] [Related]
30. [Study on the effectiveness and cost-benefit of influenza vaccine on elderly population in Beijing city]. Liu M; Liu GF; Wang Y; Zhao W; Wang L; Shi W; Wen SY Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):412-6. PubMed ID: 16185449 [TBL] [Abstract][Full Text] [Related]
31. Could a federal program to promote influenza vaccination among elders be cost-effective? Patel MS; Davis MM Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761 [TBL] [Abstract][Full Text] [Related]
33. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses. Nichol KL; Mendelman P Virus Res; 2004 Jul; 103(1-2):3-8. PubMed ID: 15163481 [TBL] [Abstract][Full Text] [Related]
35. Reducing medical service utilization by encouraging vaccines: randomized controlled trial. Berg GD; Thomas E; Silverstein S; Neel CL; Mireles M Am J Prev Med; 2004 Nov; 27(4):284-8. PubMed ID: 15488357 [TBL] [Abstract][Full Text] [Related]
36. Economic value of influenza vaccination. de Waure C; Veneziano MA; Cadeddu C; Capizzi S; Specchia ML; Capri S; Ricciardi W Hum Vaccin Immunother; 2012 Jan; 8(1):119-29. PubMed ID: 22251999 [TBL] [Abstract][Full Text] [Related]
37. Medical economics in the field of influenza--past, present and future. Szucs TD Virus Res; 2004 Jul; 103(1-2):25-30. PubMed ID: 15163484 [TBL] [Abstract][Full Text] [Related]
38. Influenza--the forgotten vaccination. Martin DJ; Schoub BD S Afr Med J; 1997 Jul; 87(7):869-71. PubMed ID: 9259719 [No Abstract] [Full Text] [Related]
40. Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan. Hoshi SL; Kondo M; Honda Y; Okubo I Vaccine; 2007 Aug; 25(35):6511-21. PubMed ID: 17681651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]